The DOI matches its Crossref record.
Potential Metabolic Interaction between St. John's Wort and Theophylline
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
Interactions Between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review
Izzo, A. A., & Ernst, E. (2009) · Drugs · doi:10.2165/11317010-000000000-00000 · Cited by 801
Barnes, J., Anderson, L. A., & Phillipson, J. D. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775910 · Cited by 749
Interactions Between Herbal Medicines and Prescribed Drugs: A Systematic Review
Izzo, A. A., & Ernst, E. (2001) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 714
Herb-Drug Interactions: A Literature Review
Hu, Z., Yang, X., Ho, P. C. L., Chan, S. Y., Heng, P. W. S., Chan, E., Duan, W., Koh, H. L., & Zhou, S. (2005) · Drugs · doi:10.2165/00003495-200565090-00005 · Cited by 633
JOHNE, A. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101944 · Cited by 586
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom, A., Cox, M. C., Acharya, M. R., & Figg, W. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.182 · Cited by 473
Interactions of Herbs with Cytochrome P450
Zhou, S., Gao, Y., Jiang, W., Huang, M., Xu, A., & Paxton, J. W. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120018248 · Cited by 397
St John's wort (Hypericum perforatum): drug interactions and clinical outcomes
Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., & Arlett, P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01683.x · Cited by 380
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Herb–drug interactions: Review and assessment of report reliability
Fugh‐Berman, A., & Ernst, E. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01469.x · Cited by 364
Budzinski, J. W., Foster, B. C., Vandenhoek, S., & Arnason, J. T. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80044-6 · Cited by 352
St John's Wort: Effect on CYP3A4 activity
Roby, C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106793 · Cited by 316
Pharmacokinetics and Bioavailability of Herbal Medicinal Products
Atul Bhattaram, V., Graefe, U., Kohlert, C., Veit, M., & Derendorf, H. (2002) · Phytomedicine · doi:10.1078/1433-187x-00210 · Cited by 315
Second thoughts about safety of St John's wort
Ernst, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00418-3 · Cited by 305
Borrelli, F., & Izzo, A. A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9146-8 · Cited by 288
St John's wort: Prozac from the plant kingdom
Di Carlo, G., Borrelli, F., Ernst, E., & Izzo, A. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01716-8 · Cited by 277
Comparison of St John's wort and imipramine for treating depression: randomised controlled trial
Woelk, H. (2000) · BMJ · doi:10.1136/bmj.321.7260.536 · Cited by 264
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Pharmacokinetic Interactions of Drugs with St John’s Wort
Zhou, S., Chan, E., Pan, S.-Q., Huang, M., & Lee, E. J. D. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042632 · Cited by 253
Proterozoic Modular Biomineralized Metazoan from the Nama Group, Namibia
Wood, R. A., Grotzinger, J. P., & Dickson, J. A. D. (2002) · Science · doi:10.1126/science.1071599 · Cited by 184
Identification of drugs that interact with herbs in drug development
Zhou, S.-F., Zhou, Z.-W., Li, C.-G., Chen, X., Yu, X., Xue, C. C., & Herington, A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.004 · Cited by 178
Tariq, S. H. (2004) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2004.02.009 · Cited by 13
Metadata
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 1999-04
- Volume
- 33
- Issue
- 4
- Pages
- 502-502
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2994590583
- Cited by
- 201
- References
- 0
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.